What is the ticker symbol for Q32 Bio?

Q32 Bio trades under the ticker QTTB on NASDAQ.

What sector does Q32 Bio operate in?

Q32 Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze QTTB in a portfolio?

PortView shows QTTB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Q32 Bio (QTTB) Stock Analysis

NASDAQHealthcareBiotechnology

$13.58-5.43%

1-year price historyRange $1.66 – $21.38

52-week range$13.58

$1.62$23.57

What Q32 Bio does

Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation. This candidate has successfully finished its Phase I clinical trial, targeting severe renal and other complement-driven conditions where patient needs are largely unmet, such as lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA-associated vasculitis. Additionally, Q32 Bio is advancing Bempikibart (ADX-914), a fully human monoclonal antibody antagonist against interleukin-7 receptor alpha. Currently in Phase II trials, Bempikibart aims to recalibrate adaptive immune responses by inhibiting signaling pathways involving interleukin-7 and thymic stromal lymphopoietin, offering potential treatment for atopic dermatitis and alopecia areata. Founded in 2017 and headquartered in Waltham, Massachusetts, Q32 Bio Inc. adopted its current name in April 2020, having previously operated as AdMIRx Inc.

Key metrics

Market cap

$404.20M

P/E (TTM)

6.56

EPS (TTM)

$2.07

Beta

-0.33

Dividend yield

0.00%

Revenue / share

$3.81

50-day avg

$14.97

200-day avg

$7.88

52-week high

$23.57

52-week low

$1.62

CEO

Jodie Pope Morrison

ETFs linked to QTTB

Broad-market and Healthcare sector ETFs an investor holding Q32 Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how QTTB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze QTTB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Q32 Bio?: Q32 Bio trades under the ticker QTTB on NASDAQ.
Which exchange is QTTB listed on?: QTTB is listed on NASDAQ.
What sector does Q32 Bio operate in?: Q32 Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze QTTB in a portfolio?: PortView shows QTTB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.